Ethionamide

In the US, Ethionamide (ethionamide systemic) is a member of the drug class nicotinic acid derivatives and is used to treat Tuberculosis, Active.

US matches:

• Ethionamide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04AD03

CAS registry number (Chemical Abstracts Service)

0000536-33-4

Chemical Formula

C8-H10-N2-S

Molecular Weight

166

Therapeutic Category

Antitubercular agent

Chemical Name

4-Pyridinecarbothioamide, 2-ethyl-

Foreign Names

• Ethionamidum (Latin)
• Ethionamid (German)
• Ethionamide (French)
• Etionamida (Spanish)

Generic Names

• Ethionamide (OS: USAN, BAN)
• Éthionamide (OS: DCF)
• Etionamide (OS: DCIT)
• Aethionamidum (IS)
• Bayer 5312 (IS: Bayer)
• Etionizina (IS)
• ETP (IS)
• TH 1314 (IS)
• Ethionamid (PH: Ph. Eur. 6)
• Ethionamide (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
• Ethionamidum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Ethatyl
  Aventis, South Africa



• Ethide
  Lupin, India



• Ethomid
  Macleods, Georgia



• Etionamida
  Bestpharma, Chile



• Eton
  Umeda, Thailand



• Etyomid
  Koçak, Turkey



• Trecator
  Wyeth, United States



• Tubermin
  Meiji Seika Kaisha, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.